IN2014MN02269A - - Google Patents

Info

Publication number
IN2014MN02269A
IN2014MN02269A IN2269MUN2014A IN2014MN02269A IN 2014MN02269 A IN2014MN02269 A IN 2014MN02269A IN 2269MUN2014 A IN2269MUN2014 A IN 2269MUN2014A IN 2014MN02269 A IN2014MN02269 A IN 2014MN02269A
Authority
IN
India
Prior art keywords
relates
extract
composition
plant
treatment
Prior art date
Application number
Inventor
Arvind Saklani
Nilesh Malpure
Parikshit Gaikwad
Satish Namdeo Sawant
Tukaram Kisanrao Mane
Somesh Sharma
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of IN2014MN02269A publication Critical patent/IN2014MN02269A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a herbal composition comprising a therapeutically effective amount of an extract of the plant as an active ingredient and optionally a pharmaceutically acceptable carrier. The invention also relates to a process for the preparation of the extract. The invention also relates to a method for the treatment of metabolic disorders using the said composition. The present invention also relates to a composition comprising a therapeutically effective amount of an extract of the plant for use in combination with one or more further therapeutically active agent for the treatment of metabolic disorders.
IN2269MUN2014 2012-04-23 2013-04-22 IN2014MN02269A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261636792P 2012-04-23 2012-04-23
PCT/IB2013/053155 WO2013160811A1 (en) 2012-04-23 2013-04-22 Composition for treating metabolic disorders

Publications (1)

Publication Number Publication Date
IN2014MN02269A true IN2014MN02269A (en) 2015-07-24

Family

ID=49482298

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2269MUN2014 IN2014MN02269A (en) 2012-04-23 2013-04-22

Country Status (16)

Country Link
US (1) US20150290265A1 (en)
EP (1) EP2841080A4 (en)
JP (1) JP2015514797A (en)
KR (1) KR20150003862A (en)
CN (1) CN104244962A (en)
AU (1) AU2013254329A1 (en)
BR (1) BR112014026326A2 (en)
CA (1) CA2870907A1 (en)
IL (1) IL235317A0 (en)
IN (1) IN2014MN02269A (en)
MX (1) MX2014012742A (en)
NZ (1) NZ701133A (en)
RU (1) RU2014145931A (en)
SA (1) SA113340494B1 (en)
TW (1) TW201343174A (en)
WO (1) WO2013160811A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3233188A4 (en) * 2014-12-19 2018-11-07 Halo Life Science, LLC Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels
MA46589A (en) 2016-10-24 2019-08-28 Yumanity Therapeutics Inc COMPOUNDS AND USES OF THE LATEST
EP3566055B1 (en) 2017-01-06 2025-03-12 Janssen Pharmaceutica NV Scd inhibitor for the treatment of neurological disorders
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
KR20200108015A (en) 2018-01-10 2020-09-16 브라이트씨드, 인크. Ways to regulate metabolism
ES3043183T3 (en) 2018-03-23 2025-11-25 Janssen Pharmaceutica Nv Compounds and uses thereof
MX2021008903A (en) 2019-01-24 2021-11-04 Yumanity Therapeutics Inc COMPOUNDS AND THEIR USES.
MX2022005682A (en) 2019-11-11 2022-08-08 Brightseed Inc Extract, consumable product and method for enriching bioactive metabolite in an extract.
EA202192047A1 (en) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. COMPOUNDS AND THEIR APPLICATIONS
KR102408566B1 (en) * 2020-04-09 2022-06-16 대한민국 Composition for Improving Skin Wrinkles Using an Extract of Terminalia bialata

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053864A (en) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk Diabetes disease preventive / therapeutic agent
JP2006188486A (en) * 2004-12-07 2006-07-20 Toyo Shinyaku:Kk Body fat accumulation-inhibiting or reducing agent
AU2005328179A1 (en) * 2005-02-23 2006-08-31 Avesthagen Limited Plant extracts and methods and uses therefore

Also Published As

Publication number Publication date
RU2014145931A (en) 2016-06-20
NZ701133A (en) 2016-08-26
IL235317A0 (en) 2014-12-31
KR20150003862A (en) 2015-01-09
MX2014012742A (en) 2015-04-08
JP2015514797A (en) 2015-05-21
CA2870907A1 (en) 2013-10-31
WO2013160811A1 (en) 2013-10-31
US20150290265A1 (en) 2015-10-15
CN104244962A (en) 2014-12-24
TW201343174A (en) 2013-11-01
BR112014026326A2 (en) 2017-06-27
AU2013254329A1 (en) 2014-11-13
EP2841080A4 (en) 2015-11-25
EP2841080A1 (en) 2015-03-04
SA113340494B1 (en) 2015-12-24

Similar Documents

Publication Publication Date Title
IN2014MN02269A (en)
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
NZ702663A (en) Nuclear transport modulators and uses thereof
HK1203356A1 (en) Pharmaceutical combinations comprising a thionucleotide analog
MX2014015004A (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof.
HK1210599A1 (en) Abuse deterrent pharmaceutical compositions for controlled release
WO2014152029A3 (en) Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
MX365939B (en) Nuclear transport modulators and uses thereof.
WO2015056094A3 (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
WO2013114394A3 (en) A polyherbal composition for skin care
EP2575842A4 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX2020001428A (en) Compositions of grapiprant and methods for using the same.
MX357704B (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
IN2014MN01933A (en)
MX2015005111A (en) Herbal composition for the prevention and treatment of tnf-î± mediated diseases.
BR112014004737A2 (en) Ambroxol Hydrochloride Compound Compound and Method of Preparation of Compound
GB2498677A (en) Extracts of cynanchum SP.and active ingredients contained therein in use of arthritis treatment
MX366309B (en) Pharmaceutical composition for treating inflammation and pain.
WO2013038200A3 (en) Neurodevelopmental disorders
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract
IN2013MU03428A (en)
WO2014170820A3 (en) A pharmaceutical combination for treating tuberculosis
UA48784U (en) Composition for treating sexual disorders in women
PH22011000489U3 (en) Solid pharmaceutical herbal compositions